Intravenous anaesthetic drug that doesn’t induce cerebral metabolism:
## **Core Concept**
The question tests knowledge of intravenous anesthetic agents and their effects on cerebral metabolism. Cerebral metabolism rate (CMR) is an important parameter in neuroanesthesia, as changes in CMR can affect cerebral blood flow and intracranial pressure. Various intravenous anesthetics have different effects on CMR.
## **Why the Correct Answer is Right**
Etomidate is known for its minimal impact on cerebral metabolism. It decreases cerebral blood flow (CBF) and cerebral metabolic rate for oxygen (CMRO2) without causing significant cerebral vasodilation. This property makes etomidate a favorable choice in neurosurgical cases where control of intracranial pressure (ICP) is crucial. Etomidate acts by enhancing the effect of GABA (gamma-aminobutyric acid) at the GABA_A receptor.
## **Why Each Wrong Option is Incorrect**
* **Option A:** Propofol decreases cerebral metabolic rate and cerebral blood flow, but it can cause cerebral vasodilation at low doses and vasoconstriction at higher doses. However, its overall effect on reducing CMR is well-documented.
* **Option B:** Thiopental significantly decreases cerebral metabolic rate, cerebral blood flow, and consequently, intracranial pressure. It is often used in neuroanesthesia for this reason.
* **Option D:** Ketamine can increase cerebral blood flow and cerebral metabolic rate, which might seem detrimental in certain neurosurgical scenarios. However, its effects on cerebral metabolism and blood flow are more complex and can vary depending on the context.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that etomidate is often chosen in patients with hemodynamic instability or in neurosurgical cases where maintaining stable cerebral perfusion and avoiding increases in ICP are critical. Its minimal impact on cardiovascular stability and cerebral metabolism makes it a valuable agent in specific clinical scenarios.
## **Correct Answer:** . Etomidate